Get all premium features to the best stock analysis tool

An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences: Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Monday, March 16, 2026. Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer will participate in a virtual presentation at 9:20 a.m. Eastern Time / 8:20 a.m. Central Time on Mon.

Addus HomeCare Corporation (ADUS) Q4 2025 Earnings Call Transcript

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that management will participate in the Raymond James & Associates 47th Annual Institutional Investors Conference, which takes place March 1 – 4, 2026, in Orlando, Florida. In connection with the conference, there will be a live broadcast and replay of the Company's presentation available under the Investor Relations section of the Company's website, www.addus.com, st.

Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Addus HomeCare (ADUS) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.38 per share a year ago.

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Highlights: Net Service Revenues Increase 25.6% to $373.1 Million Net Income of $29.8 Million, or $1.61 per Diluted Share Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77 Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million Cash Flow f.